The world of electronics manufacturing has evolved dramatically over the past decades. What began largely as basic assembly of printed circuit boards (PCBs) has now transformed into full-fledged, integrated manufacturing ecosystems. These ecosystems provide not only assembly, but also design support, testing, logistics, quality control, and supply-chain management for original equipment manufacturers (OEMs). This
Duchenne Muscular Dystrophy (**DMD**) is a severe, progressive, X-linked genetic disorder caused by mutations in the *DMD* gene, which is responsible for producing the essential protein **dystrophin**, a critical component that stabilizes muscle cell membranes. The absence of functional dystrophin leads to chronic muscle degeneration, inflammation, and eventual replacement of muscle tissue with fat and fibrosis, resulting in relentless, debilitating physical decline. Recent scientific breakthroughs are rapidly transforming the therapeutic outlook, shifting the focus from purely supportive care to highly sophisticated, mutation-specific genetic and molecular interventions.
The core strategy in modern DMD treatment is to address the underlying genetic fault. One established approach is **Exon-Skipping Therapy**, which utilizes antisense oligonucleotides (ASOs) to mask specific faulty sections (exons) of the *DMD* gene transcript. This molecular 'skipping' enables the cellular machinery to bypass the mutation, resulting in the production of a truncated, but partially functional, dystrophin protein. While not a cure, this…
Welcome to the group! You can connect with other members, get updates and share videos.
